AADI

Aadi Bioscience, Inc.

2.09 USD
+0.02 (+0.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aadi Bioscience, Inc. stock is up 20.81% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 February’s closed higher than January.

About Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin.